![David Johnson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Johnson
Directeur des opérations chez
VERA THERAPEUTICS, INC.
Fortune : 224 273 $ au 31/05/2026
Profil
David L.
Johnson currently works at Caribou Biosciences, Inc., as Independent Director from 2022 and Vera Therapeutics, Inc., as Chief Operating Officer from 2024.
Mr. Johnson also formerly worked at Gilead Sciences, Inc., as Vice President-Sales & Marketing from 2003 to 2018 and Global Blood Therapeutics, Inc., as Chief Commercial Officer from 2018 to 2022.
Mr. Johnson received his undergraduate degree from the University of Puget Sound and Masters Business Admin degree from Kenan-Flagler Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/03/2026 | 6 314 ( 0,01% ) | 224 273 $ | 31/05/2026 | |
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de David Johnson
| Sociétés | Poste | Début |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Directeur/Membre du Conseil | 11/05/2022 |
| VERA THERAPEUTICS, INC. | Directeur des opérations | 01/07/2024 |
Anciens postes connus de David Johnson
| Sociétés | Poste | Fin |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2022 |
| GILEAD SCIENCES, INC. | Sales & Marketing | 01/01/2018 |
Formation de David Johnson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
University of Puget Sound
 University of Puget Sound Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kenan-Flagler Business School
 Kenan-Flagler Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
